CRON
Price
$3.23
Change
+$0.01 (+0.31%)
Updated
Oct 2 closing price
Capitalization
1.26B
37 days until earnings call
Intraday BUY SELL Signals
WEED
Price
$20.60
Change
-$0.49 (-2.32%)
Updated
Oct 2 closing price
Net Assets
7.54M
Intraday BUY SELL Signals
Interact to see
Advertisement

CRON vs WEED

CRON vs WEED Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRON vs. WEED commentary
Oct 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Hold and WEED is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CRON: Fundamental Ratings
CRON
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRONWEED
RSI
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
88%
COMPARISON
Comparison
Oct 05, 2026
Stock price -- (CRON: $3.22)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 0 FA rating(s) are green while .

  • CRON’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 3 TA indicator(s) are bullish.

  • CRON’s TA Score: 3 bullish, 5 bearish.

Price Growth

CRON (@Pharmaceuticals: Generic) experienced а -3.44% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.61%. For the same industry, the average monthly price growth was -8.00%, and the average quarterly price growth was +30.03%.

Reported Earning Dates

CRON is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
CRON
Daily Signal:
Gain/Loss:
WEED
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSCC33.430.55
+1.66%
Invesco S&P SmallCap Consumer Staples ETF (PSCC)
AMID37.050.44
+1.19%
Argent Mid Cap ETF (AMID)
OIH382.701.58
+0.41%
VanEck Oil Services ETF (OIH)
FEMD34.36N/A
N/A
First Eagle Mid Cap Equity ETF (FEMD)
RUNN32.68-0.15
-0.45%
Running Oak Efficient Growth ETF (RUNN)

WEED and

Correlation & Price change

A.I.dvisor tells us that WEED and TPB have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WEED and TPB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WEED
1D Price
Change %
WEED100%
-2.30%
TPB - WEED
10%
Poorly correlated
+0.58%
OGI - WEED
5%
Poorly correlated
-2.97%
CRON - WEED
3%
Poorly correlated
+0.47%